Rheumatology (Oxford, England) · 2026
Urological manifestations in familial Mediterranean fever excluding renal amyloidosis: a systematic review.
СтатьяСистематический обзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ozcan Aziz Kutay, Karaoglan Baris, Gundogdu Berkay, Sahin Cansu, Simsekoglu Muhammed Fatih, Ugurlu Serdal
Аннотация
OBJECTIVES: To systematically review the spectrum of urological manifestations and fertility outcomes reported in FMF patients, excluding renal amyloidosis-related involvement.
METHODS: A systematic search was conducted according to PRISMA 2020 Guidelines in PubMed, Web of Science, Google Scholar and Cochrane Library, up to 4 July 2025. Studies that included FMF patients with a confirmed urological pathology were eligible. Data was extracted and presented through descriptive statistics.
RESULTS: A total of 110 records were published between 1973 and 2025, of which 38 met the inclusion criteria (14 case reports, 10 case series, 10 cross-sectional and 4 cohort studies) and covered a total of 2040 patients (mean ± s.d. age 23.35 ± 16 years; 43.2% female). Results included acute scrotum (n = 64) with 75% of recurrence, testicular amyloidosis (n = 40) confirmed with biopsy, epididymo-orchitis (n = 25) with fever present in 84%, testicular torsion (n = 4), hydrocele (n = 4), and bladder amyloidosis (n = 2). Among 189 semen analyses reported, azoospermia and oligospermia were in 26.9% and 14.8% of cases. Infertility was reported in patients with testicular amyloidosis.
CONCLUSION: Our study results show that acute scrotum and epididymo-orchitis were the most frequent urological manifestations in FMF, and testicular amyloidosis and fertility impairment were also notable. These findings highlight the importance of considering urological involvement as part of the FMF spectrum in clinical practice.
METHODS: A systematic search was conducted according to PRISMA 2020 Guidelines in PubMed, Web of Science, Google Scholar and Cochrane Library, up to 4 July 2025. Studies that included FMF patients with a confirmed urological pathology were eligible. Data was extracted and presented through descriptive statistics.
RESULTS: A total of 110 records were published between 1973 and 2025, of which 38 met the inclusion criteria (14 case reports, 10 case series, 10 cross-sectional and 4 cohort studies) and covered a total of 2040 patients (mean ± s.d. age 23.35 ± 16 years; 43.2% female). Results included acute scrotum (n = 64) with 75% of recurrence, testicular amyloidosis (n = 40) confirmed with biopsy, epididymo-orchitis (n = 25) with fever present in 84%, testicular torsion (n = 4), hydrocele (n = 4), and bladder amyloidosis (n = 2). Among 189 semen analyses reported, azoospermia and oligospermia were in 26.9% and 14.8% of cases. Infertility was reported in patients with testicular amyloidosis.
CONCLUSION: Our study results show that acute scrotum and epididymo-orchitis were the most frequent urological manifestations in FMF, and testicular amyloidosis and fertility impairment were also notable. These findings highlight the importance of considering urological involvement as part of the FMF spectrum in clinical practice.